Neoplasms
Conditions
Interventions
This is a 2-arm controled, unblinded, prospective randomized clinical trial. The study was responsible for analyzing a cohort of 427 patients, over 50 years old, with members of both sexes, with solid
Sponsors
Instituto Brasileiro de Controle do Câncer - IBCC/ Oncologia Clínica - SP
Instituto Brasileiro de Controle do Câncer - IBCC/ Oncologia Clínica - SP
Eligibility
Age
50 Years to No maximum
Inclusion criteria
Inclusion criteria: Volunteers over 50 years of age; of both genders; with solid neoplasms; in elective surgical programming under general anesthesia; no uncompensated comorbidities; with normal physical examination at the time of preoperative clinical evaluation
Exclusion criteria
Exclusion criteria: Abnormal physical examination at the time of preoperative clinical evaluation; age below 50 years; deaths prior to elective surgical treatment under general anesthesia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome 1: It is expected to find no significant differences regarding in-hospital morbidity and mortality between the group of patients who underwent preoperative electrocardiogram and the group of patients who did not. Evaluated through the length of hospital stay for the proposed procedure, and any intercurrence that resulted in death or increased the length of stay was considered an adverse event.;Observed outcome 1: No significant difference was observed regarding in-hospital morbidity and mortality between the group of patients who underwent preoperative electrocardiogram and the group of patients who did not. Evaluated through the length of hospital stay for the proposed procedure, and any intercurrence that resulted in death or increased the length of stay was considered an adverse event. It was possible to observe the occurrence of 23 (5.4%) adverse outcomes, with three deaths (0.7%). No significant difference was observed in terms of postoperative complications between the groups that underwent preoperative electrocardiogram or not (6.5% x 4.2%; OR=1.59 CI95% 0.67-3.75, p=0.289). | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected outcome 2: It is expected not to find significant differences regarding in-hospital morbidity and mortality between the group of patients who presented altered preoperative electrocardiogram results, the group of patients with normal results and also between the group that did not undergo the exam. Evaluated through the length of hospital stay for the proposed procedure, and any intercurrence that resulted in death or increased the length of stay was considered an adverse event.;Observed outcome 2: No significant difference was observed regarding in-hospital morbidity and mortality between the group of patients who presented altered preoperative electrocardiogram results, the group of patients with normal results and also between the group that did not undergo the exam. Evaluated through the length of hospital stay for the proposed procedure, and any intercurrence that resulted in death or increased the length of stay was considered an adverse event. It was possible to observe the occurrence of 23 (5.4%) adverse outcomes, with three deaths (0.7%). When comparing the group with electrocardiographic abnormalities with those with normal electrocardiogram and also with the group that was not submitted to the exam, there is no significant difference between the groups in relation to the occurrence of adverse events (11.8% x 6.1% x 4.2%. p =0.402). Also, when comparing only the patients who underwent the electrocardiogram, those in which the electrocardiogram was normal with those who had some abnormality, and as expected, no difference was observed either (p=0.307). | — |
Countries
Brazil
Contacts
Public ContactAlexandre Coutinho
Instituto Brasileiro de Controle do Câncer - IBCC/ Oncologia Clínica - SP
Outcome results
None listed